Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 19840151)

1.

Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies.

Bushe CJ, Bradley AJ, Doshi S, Karagianis J.

Int J Clin Pract. 2009 Dec;63(12):1743-61. doi: 10.1111/j.1742-1241.2009.02224.x. Epub 2009 Oct 19. Review.

PMID:
19840151
2.

Management of atypical antipsychotic drug-induced weight gain: focus on metformin.

Miller LJ.

Pharmacotherapy. 2009 Jun;29(6):725-35. doi: 10.1592/phco.29.6.725. Review.

PMID:
19476423
3.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
4.

Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: a 12-week double-blind, placebo-controlled pilot study.

Baptista T, Uzcátegui E, Rangel N, El Fakih Y, Galeazzi T, Beaulieu S, de Baptista EA.

Psychiatry Res. 2008 May 30;159(1-2):250-3. doi: 10.1016/j.psychres.2008.01.011. Epub 2008 Apr 18.

PMID:
18374423
5.

A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain.

Henderson DC, Fan X, Copeland PM, Borba CP, Daley TB, Nguyen DD, Zhang H, Hayden D, Freudenreich O, Cather C, Evins AE, Goff DC.

Acta Psychiatr Scand. 2007 Feb;115(2):101-5.

PMID:
17244173
6.

A systematic review of metformin to limit weight-gain with atypical antipsychotics.

Lee YJ, Jeong JH.

J Clin Pharm Ther. 2011 Oct;36(5):537-45. doi: 10.1111/j.1365-2710.2011.01255.x. Epub 2011 Mar 21. Review.

PMID:
21418264
7.

Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.

Ellinger LK, Ipema HJ, Stachnik JM.

Ann Pharmacother. 2010 Apr;44(4):668-79. doi: 10.1345/aph.1M550. Epub 2010 Mar 16. Review.

PMID:
20233913
8.

Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial.

Baptista T, Rangel N, Fernández V, Carrizo E, El Fakih Y, Uzcátegui E, Galeazzi T, Gutiérrez MA, Servigna M, Dávila A, Uzcátegui M, Serrano A, Connell L, Beaulieu S, de Baptista EA.

Schizophr Res. 2007 Jul;93(1-3):99-108. Epub 2007 May 8.

PMID:
17490862
9.

Metabolic syndrome with the atypical antipsychotics.

Pramyothin P, Khaodhiar L.

Curr Opin Endocrinol Diabetes Obes. 2010 Oct;17(5):460-6. doi: 10.1097/MED.0b013e32833de61c. Review.

PMID:
20717020
10.

Management of weight gain associated with antipsychotics.

Birt J.

Ann Clin Psychiatry. 2003 Mar;15(1):49-58. Review.

PMID:
12839432
11.

[Metabolic side effects of risperidone in early onset schizophrenia].

Goeb JL, Marco S, Duhamel A, Kechid G, Bordet R, Thomas P, Delion P, Jardri R.

Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1. French.

PMID:
20620267
12.

A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.

Henderson DC, Copeland PM, Daley TB, Borba CP, Cather C, Nguyen DD, Louie PM, Evins AE, Freudenreich O, Hayden D, Goff DC.

Am J Psychiatry. 2005 May;162(5):954-62.

PMID:
15863798
13.

Gaining: pediatric patients and use of atypical antipsychotics.

Towbin KE.

Am J Psychiatry. 2006 Dec;163(12):2034-6. No abstract available.

PMID:
17151148
14.

Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial.

Baptista T, Martínez J, Lacruz A, Rangel N, Beaulieu S, Serrano A, Arapé Y, Martinez M, de Mendoza S, Teneud L, Hernández L.

Can J Psychiatry. 2006 Mar;51(3):192-6.

PMID:
16618011
15.

Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis.

Björkhem-Bergman L, Asplund AB, Lindh JD.

J Psychopharmacol. 2011 Mar;25(3):299-305. doi: 10.1177/0269881109353461. Epub 2010 Jan 15. Review.

PMID:
20080925
16.

Antipsychotic-associated weight gain and clinical outcome parameters.

Blin O, Micallef J.

J Clin Psychiatry. 2001;62 Suppl 7:11-21. Review.

PMID:
11346191
17.

The adjunctive use of metformin to treat or prevent atypical antipsychotic-induced weight gain: a review.

Khan AY, Macaluso M, McHale RJ, Dahmen MM, Girrens K, Ali F.

J Psychiatr Pract. 2010 Sep;16(5):289-96. doi: 10.1097/01.pra.0000388624.91039.a3. Review.

PMID:
20859106
18.
19.

[Weight gain during treatment with antipsychotics: clinical relevance, pathophysiology, and therapeutical strategies].

Himmerich H, Schuld A, Pollmächer T.

Psychiatr Prax. 2004 Nov;31 Suppl 2:S233-7. Review. German.

PMID:
15586316
20.

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian.

PMID:
18773755
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk